by BENJAMIN WERNER CHRISTENSEN, translated by daniel pedersen
Pharmaceutical firm Lundbeck is hoping to avoid the costly blunders of the past, and has therefore halted one of its drug hopes meant to treat the feared brain condition known as Alzheimer’s disease. At least for the time being.
”We’ve parked Lu AF97908 because we don’t have a single piece of evidence in the world that such an antibody works,” says Johan Luthman, head of research and development at Lundbeck.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
WS Audiology brings in head of EMEA region from Coloplast
The hearing aid manufacturer has appointed Coloplast’s now outgoing president for emerging markets as president for the EMEA region.
Dupixent could dominate pediatric eczema market for up to a decade, analysis finds
Sanofi and Regeneron will be able to call themselves market leaders within atopic eczema treatment for children aged 6 months to 5 for years to come, according to Globaldata.
FDA advisors support approval for Ferring's intestinal infection medicine
All signs indicate that Ferring Pharmaceuticals is on the cusp of being market authorized for its biologic candidate against C. difficile infection.
Pharmacosmos expects massive growth in four years
The company’s new chief executive has ambitions of reaching a DKK 2.5bn (USD 325m) revenue within the time frame.
The Lundbeck Foundation, ATP, LEGO asset manager join forces on secretive project
Three of Denmark’s biggest funds have come together for a yet unknown project, which includes the establishment of three new firms.
CMC Writer 
Senior/lead consultant at Emendo Engineering 
Pharmacovigliance (Associate) Director or Senior Specialist 
Head of Commercial / Sales Manager, Denmark 
Scientist Radiochemistry 
Ambitious Business Relationship Manager for the Danish Medicines Agency 
Manager of QA, BHS Logistics 
Lab Manager 
Clinical Project Lead 
Pharmacovigilance & Regulatory Assistant with an interest in non-fiction 
Sales Manager Denmark 
Senior CMC Regulatory Manager 
Process Supporter working with SAP 
Chief Business Officer 
Product specialist 
Vice President, Medical Affairs 
KLIFO is looking for a Compliance Coordinator for our Glostrup office